Assuring the Quality of Biological Medicines
Our mission is to safeguard and enhance public health through standardisation and control of biological products used in medicine.
NIBSC is uniquely placed to fulfil this role, operating at the interface between leading edge scientific research, product development, regulation and policy.
At the heart of our work is the preparation, storage and distribution of WHO International Standards and Reference Materials to provide benchmarks for product quality. In addition we provide product testing services to ensure compliance with product specifications. These activities are underpinned by leading edge scientific research and development expertise covering a wide range of scientific disciplines.
This project was set up to obtain characterised materials for studying and
developing diagnostic tests for Creutzfeldt-Jakob Disease (CJD).
The centre develops and provides viruses and reagents for seasonal and pandemic influenza vaccine production
The Bank works with and for the scientific and clinical community to assure
the quality of human stem cell lines used in research and therapy.
Originally established in 1989 the facility has grown steadily and the repository now houses over 1900 reagents.
